Significant Effect of Raloxifene on Bone in Hemodialysis Patients

Author Information
Article Notes and Dates
To Cite : Ravn P. Significant Effect of Raloxifene on Bone in Hemodialysis Patients, Int J Endocrinol Metab. 2012 ;10(4):636-637. doi: 10.5812/ijem.6251.
Copyright: Copyright © 2012, International Journal of Endocrinology and Metabolism. .
Footnotes
References
  • 1. Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando Y, et al. Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients With Type 2 Diabetes. Int J Endocrinol Metab. 2012; 10(2): 464-9[DOI]
  • 2. Fusaro M, D'Angelo A, Scalzo G, Gallieni M, Giannini S, Guglielmi G. Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis. J Endocrinol Invest. 2010; 33(5): 347-52[PubMed]
  • 3. Adami S. Bone health in diabetes: considerations for clinical management. Curr Med Res Opin. 2009; 25(5): 1057-72[DOI][PubMed]
  • 4. Kanis JA, Johansson H, Oden A, McCloskey EV. A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone. 2010; 47(4): 729-35[DOI][PubMed]
  • 5. Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008; 12(3): 157-70[DOI]
  • 6. Boonen S, Nicholson P. Assessment of femoral bone fragility and fracture risk by ultrasonic measurements at the calcaneus. Age Ageing. 1998; 27(2): 231-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check